Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness

Aim. We aimed to compare effectiveness of new  class III antiarrhythmic drug  Refralon with direct current  cardioversion (DCC) in patients with persistent atrial fibrillation (AF).Material and methods. 60  patients with persistent AF were  randomized to groups  of DCC (n=30) and  pharmacologic conv...

Full description

Bibliographic Details
Main Authors: N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2018-11-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
atrial fibrillation
direct current cardioversion
pharmacological cardioversion
effectiveness
safety
refralon
Online Access:https://www.rpcardio.com/jour/article/view/1749

Similar Items

Similar Items